Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients | Zendy

Laura B. Ramsey | Zendy; Henry H. Ong | Zendy; Jonathan S. Schildcrout | Zendy; Yaping Shi | Zendy; Leigh Anne Tang | Zendy; J. Kevin Hicks | Zendy; Nihal El Rouby | Zendy; Larisa H. Cavallari | Zendy; Sony Tuteja | Zendy; Christina L. Aquilante | Zendy; Amber L. Beitelshees | Zendy; Daniel L. Lemkin | Zendy; Kathryn Blake | Zendy; Helen Williams | Zendy; James J. Cimino | Zendy; Brittney H. Davis | Zendy; Nita A. Limdi | Zendy; Philip E. Empey | Zendy; Christopher M. Horvat | Zendy; David Kao | Zendy; Gloria Lipori | Zendy; Marc B. Rosenman | Zendy; Todd C. Skaar | Zendy; Evgenia Teal | Zendy; Almut G. Winterstein | Zendy; Aniwaa Owusu Obeng | Zendy; Daria Salyakina | Zendy; Apeksha Gupta | Zendy; Joshua Gruber | Zendy; Jennifer McCaffertyFernandez | Zendy; Jeffrey R. Bishop | Zendy; Zach Rivers | Zendy; Ashley Benner | Zendy; Bani Tamraz | Zendy; Janel Long-Boyle | Zendy; Josh F. Peterson | Zendy; Sara L. Van Driest | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients

Author(s) -

Laura B. Ramsey,

Henry H. Ong,

Jonathan S. Schildcrout,

Yaping Shi,

Leigh Anne Tang,

J. Kevin Hicks,

Nihal El Rouby,

Larisa H. Cavallari,

Sony Tuteja,

Christina L. Aquilante,

Amber L. Beitelshees,

Daniel L. Lemkin,

Kathryn Blake,

Helen Williams,

James J. Cimino,

Brittney H. Davis,

Nita A. Limdi,

Philip E. Empey,

Christopher M. Horvat,

David Kao,

Gloria Lipori,

Marc B. Rosenman,

Todd C. Skaar,

Evgenia Teal,

Almut G. Winterstein,

Aniwaa Owusu Obeng,

Daria Salyakina,

Apeksha Gupta,

Joshua Gruber,

Jennifer McCaffertyFernandez,

Jeffrey R. Bishop,

Zach Rivers,

Ashley Benner,

Bani Tamraz,

Janel Long-Boyle,

Josh F. Peterson,

Sara L. Van Driest

Publication year - 2020

Publication title -

jama network open

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.278

H-Index - 39

ISSN - 2574-3805

DOI - 10.1001/jamanetworkopen.2020.29411

Subject(s) - medicine , medical prescription , interquartile range , medical record , dosing , pharmacogenetics , health care , pediatrics , family medicine , genotype , biochemistry , chemistry , economics , pharmacology , gene , economic growth

This cross-sectional study assesses potential opportunities for genotype-guided prescribing in pediatric populations among multiple health systems by examining the prevalence of prescriptions for each drug with the highest level of evidence and estimating the prevalence of potentially actionable prescribing decisions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research